Intra-islet glucagon signalling regulates beta-cell connectivity, first-phase insulin secretion and glucose homoeostasis

Intra-islet glucagon signalling regulates beta-cell connectivity, first-phase insulin secretion and glucose homoeostasis

Objective: Type 2 diabetes (T2D) is characterised by the loss of first-phase insulin secretion. We studied mice with β-cell selective loss of the glucagon receptor (Gcgrfl/fl X Ins-1Cre), to investigate the role of intra-islet glucagon receptor (GCGR) signalling on pan-islet [Ca2+]I activity and ins...

Podrobná bibliografie
Hlavní autoři:	Suba, K., Patel, Y., Martin-Alonso, A., Hansen, B., Xu, X., Roberts, A., Norton, M., Chung, P., Shrewsbury, J., Kwok, R., Kalogianni, V., Chen, S., Liu, X., Kalyviotis, K., Rutter, Guy A., Jones, B., Minnion, J., Owen, B. M., Pantazis, P., Distaso, W., Drucker, D. J., Tan, T. M., Bloom, S. R., Murphy, K. G., Salem, V.
Další autoři:	Lee Kong Chian School of Medicine (LKCMedicine)
Médium:	Journal Article
Jazyk:	English
Vydáno:	2024
Témata:	Medicine, Health and Life Sciences Calcium waves Glucagon
On-line přístup:	https://hdl.handle.net/10356/179717

Podobné jednotky

Intra-islet glucagon signalling regulates beta-cell connectivity, first-phase insulin secretion and glucose homoeostasis
Autor: K. Suba, a další
Vydáno: (2024-07-01)

Dietary protein defends lean mass and maintains the metabolic benefits of glucagon receptor agonism in mice
Autor: Tatiana Lopes, a další
Vydáno: (2024-11-01)

Secretion of glucagon, GLP-1 and GIP may be affected by circadian rhythm in healthy males
Autor: Dorte B. Zilstorff, a další
Vydáno: (2024-03-01)

Characterization of LY3324954 a long-acting glucagon-receptor agonist
Autor: William Roell, a další
Vydáno: (2025-01-01)

Imeglimin enhances glucagon secretion through an indirect mechanism and improves fatty liver in high‐fat, high‐sucrose diet‐fed mice
Autor: Osamu Kikuchi, a další
Vydáno: (2024-09-01)

Cystic fibrosis-related diabetes is associated with reduced islet protein expression of GLP-1 receptor and perturbation of cell-specific transcriptional programs
Autor: Sina A. Gharib, a další
Vydáno: (2024-10-01)

Different post-pancreatectomy glucagon responses to a meal test between surgical approaches
Autor: Tsuguka Matsuda, a další
Vydáno: (2023-11-01)

The MODY-associated KCNK16 L114P mutation increases islet glucagon secretion and limits insulin secretion resulting in transient neonatal diabetes and glucose dyshomeostasis in adults
Autor: Arya Y Nakhe, a další
Vydáno: (2024-05-01)

Variable glucagon metabolic actions in diverse mouse models of obesity and type 2 diabetes
Autor: Yuqin Wu, a další
Vydáno: (2024-12-01)

Commentary on “Electroacupuncture Inhibited Spinal Glial Activation in Neuropathic Pain via Glucagon-like Peptide 1/Glucagon-like Peptide 1 Receptor Signaling”
Autor: Hulya Karatas
Vydáno: (2024-09-01)

Emerging glucagon-based therapies in diabetes mellitus: Toward a better future in diabetes care
Autor: Shahini Winson Gnanathayalan, a další
Vydáno: (2024-01-01)

Physiology and pharmacology of glucagon-like peptide-1 receptor
Autor: D. V. Kurkin, a další
Vydáno: (2024-01-01)

The neglected PCK1/glucagon (inter)action in nutrient homeostasis beyond gluconeogenesis: Disease pathogenesis and treatment
Autor: Romina Bertinat, a další
Vydáno: (2025-04-01)

Autophagy-lysosome pathway in insulin & glucagon homeostasis
Autor: Yi Wu, a další
Vydáno: (2025-02-01)

The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor - An Update
Autor: Agnieszka Jakubowska, a další
Vydáno: (2024-02-01)

Glucagon and insulin immunopositivity of mast cells in porcine gallbladder
Autor: I. Stefanov, a další
Vydáno: (2024-12-01)

Glucagon-Like Peptide-1 Based Therapies: A New Horizon in Obesity Management
Autor: Jang Won Son, a další
Vydáno: (2024-04-01)

Evolution of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes
Autor: Gagik R. Galstyan, a další
Vydáno: (2017-10-01)

EXPRESSION OF INSULIN, GLUCAGON, SOMATOSTATIN, AND PANCREATIC POLYPEPTIDE IN THE PANCREAS OF THE EURASIAN MOORHEN (Gallinula chloropus)
Autor: Ahmed Abdellatif
Vydáno: (2023-07-01)

Effects of Low-Dose Glucagon on Subcutaneous Insulin Absorption in Pigs
Autor: Ingrid Anna Teigen, M.D., Ph.D., a další
Vydáno: (2024-01-01)

Glucagon: Physiological and Pharmacological Functions and Pathophysiological Significance in Type 2 Diabetes
Autor: Tadahiro Kitamura
Vydáno: (2024-02-01)

Abnormal late postprandial glucagon response in type 1 diabetes is a function of differences in stimulated C-peptide concentrations
Autor: Lingyu Zhang, a další
Vydáno: (2024-08-01)

Islets secretory capacity determines glucose homoeostasis in the face of insulin resistance
Autor: P Wiesli, a další
Vydáno: (2004-09-01)

High fructose rewires gut glucose sensing via glucagon-like peptide 2 to impair metabolic regulation in mice
Autor: Eya Sellami, a další
Vydáno: (2025-03-01)

Potential determinants of low circulating glucagon‐like peptide 2 concentrations in Zambian children with non‐responsive stunting
Autor: Ellen Besa, a další
Vydáno: (2023-04-01)

Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism
Autor: Hoffman Simon, a další
Vydáno: (2024-08-01)

Lowest Glucagon/Highest C-Peptide in Oral Glucose Tolerance Test: Clinical Utility in Monitoring Glucose Control in Type 2 Diabetes Mellitus
Autor: Chang L, a další
Vydáno: (2024-04-01)

Female glucagon receptor knockout mice are prone to steatosis but resistant to weight gain when fed a MASH‐promoting GAN diet and a high‐fat diet
Autor: Katrine D. Galsgaard, a další
Vydáno: (2025-02-01)

From classical dualistic antagonism to hormone synergy: potential of overlapping action of glucagon, insulin and GLP-1 for the treatment of diabesity
Autor: Svjatoslavs Kistkins, a další
Vydáno: (2024-05-01)

Assessment of glucagon receptor occupancy by Positron Emission Tomography in non-human primates
Autor: Eriksson, Olof, a další
Vydáno: (2020)

Health Technology Assessment: Evaluation of 7 Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus
Autor: Xie Z, a další
Vydáno: (2024-04-01)

Healthcare professionals' perceptions and management of obesity & knowledge of glucagon, GLP‐1, GIP receptor agonists, and dual agonists
Autor: W. Timothy Garvey, a další
Vydáno: (2024-06-01)

Nephroprotective potential of glucagon-like peptide-1 receptor agonists
Autor: Minara S. Shamkhalova, a další
Vydáno: (2020-04-01)

Diabetes and obesity. The role of agonists glucagon-like peptide-1 of in the treatment of type 2 diabetes
Autor: Nina A. Petunina, a další
Vydáno: (2018-09-01)

Predictors of effectiveness of glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes and obesity
Autor: Ekaterina V. Tikhonenko, a další
Vydáno: (2018-12-01)

Glucagon-like peptide 1 receptor activation: anti-inflammatory effects in the brain
Autor: Yolanda Diz-Chaves, a další
Vydáno: (2024-01-01)

The role of glucagon-like peptide-1 receptor agonists (GLP1-RAs) in the management of the hypertensive patient with metabolic syndrome: a position paper from the Korean society of hypertension
Autor: Hae Young Lee, a další
Vydáno: (2024-09-01)

The Therapeutic Potential of Glucagon-like Peptide 1 Receptor Agonists in Traumatic Brain Injury
Autor: Anja Harej Hrkać, a další
Vydáno: (2024-10-01)

Non-functional alpha-cell hyperplasia with glucagon-producing NET: a case report
Autor: Catarina Cidade-Rodrigues, a další
Vydáno: (2024-09-01)

Glucagon: a potential protective factor against peripheral nerve compromise in patients with type 2 diabetes and obesity
Autor: Hao Hua, a další
Vydáno: (2025-01-01)